A review of life science events reported on this week by MedCity News:
Medtronic hypertension device tops Cleveland Clinic medical innovations. The device, which Medtronic acquired through its $800 million acquisition of Ardian earlier this year, is called the Symplicity Catheter System. It works via a process known as renal denervation, or ablation of the nerves that line the renal arteries, and could represent a way to control resistant hypertension without drugs.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Envoy Medical hearing aid video goes viral; 2 million+ views in a week. Sarah Churman, 29, posted the video of her hearing her own voice for the first time on her sloanchurman YouTube account. In five days the video has gathered more than 2.1 million views on YouTube and the video (and Esteem) were featured everywhere from The Washington Post to The Huffington Post.
Change of heart: Why Pozen now wants to partner its cardiovascular drug. “It really comes down to how we can maximize the asset,” Chief Commercial Officer Liz Cermak said in a conference call with analysts. “We’re a little company with a limited amount of resources.”
Case Western Reserve’s most promising med-tech startups. As director of the Coulter-Case Translational Research Partnership, Drummond is behind a $1 million fund that often invests in technologies spun out of Case. Drummond discusses a few spinoff companies, including next-generation insulin developer Thermalin Diabetes and stroke device start Swallowing Solutions.
Cleveland Clinic CEO: Comparative effectiveness will ‘chill’ innovation. Comparative effectiveness research, one of the key tenets of federal health reform, “seems good on first blush” but will have a chilling effect on medical innovation, Cleveland Clinic CEO Dr. Toby Cosgrove said.
